BMC BioinformaticsBioinformaticsPeer-reviewed journal article
vCOMBAT: a Novel Tool to Create and Visualize a COmputational Model of Bacterial Antibiotic Target-binding
Vi Ngoc-Nha TraniD, Alireza ShamsiD, Sinan Ascioglu, Antal MartinecziD, Jingyi LiangiD, Fabrizio ClarelliiD, Rafal J. MostowyiD, Ted CoheniD, Pia Abel zur WieschiD
Abstract
MotivationAs antibiotic resistance creates a significant global health threat, we need not only to accelerate the development of novel antibiotics but also to develop better treatment strategies using existing drugs to improve their efficacy and prevent the selection of further resistance. We require new tools to rationally design dosing regimens to from data collected in early phases of antibiotic and dosing development. Mathematical models such as mechanistic pharmacodynamic drug-target binding explain mechanistic details of how the given drug concentration affects its targeted bacteria. However, there are no available tools in the literature that allows non-quantitative scientists to develop computational models to simulate antibiotic-target binding and its effects on bacteria. ResultsIn this work, we have devised an extension of a mechanistic binding-kinetic model to incorporate clinical drug concentration data. Based on the extended model, we develop a novel and interactive web-based tool that allows non-quantitative scientists to create and visualize their own computational models of bacterial antibiotic target-binding based on their considered drugs and bacteria. We also demonstrate how Rifampicin affects bacterial populations of Tuberculosis (TB) bacteria using our vCOMBAT tool. AvailabilityvCOMBAT online tool is publicly available at https://combat-bacteria.org/.
- Citations
- 2
- FWCI
- 0.30
- Field percentile
- 48th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drug-target binding quantitatively predicts optimal antibiotic dose levels
F. Clarelli, A. Palmer, … P. Abel zur Wiesch·bioRxiv·Jun 27, 2019
- A Mechanistic Approach to Optimize Combination Antibiotic Therapy
Fabrizio Clarelli, Pierre Ankomah, … Pia Abel zur Wiesch·BiosystemsPeer-reviewed·Dec 24, 2024
- stormTB: A web-based simulator of a murine minimal-PBPK model for anti-tuberculosis treatments.
Roberto Visintainer, Anna Fochesato, … Luca Marchetti·Frontiers in PharmacologyPeer-reviewed·Jan 8, 2025
- Repurposed kinase inhibitors and β-lactams as a novel therapy for antibiotic resistant bacteria
Nathan Wlodarchak, Nathan Teachout, … Rob Striker·bioRxiv·Oct 7, 2017
- Hybrid dynamic pharmacophore models as effective tools to identify novel chemotypes for anti-TB inhibitor design: A case study with Mtb-DapB
Chinmayee Choudhury, Anshu Bhardwaj·Frontiers in ChemistryPeer-reviewed·Dec 2, 2020
- Minimal biophysical model of combined antibiotic action
B. Kavcic, G. Tkacik, T. Bollenbach·bioRxiv·Apr 18, 2020